230+ SPEAKERS, INCLUDING:

 

 

ALL 2020 SPEAKERS

 

Stewart Abbot, Chief Scientific Officer, Adicet Bio

Stewart Abbot | Chief Scientific Officer | Adicet Bio » speaking at Advanced Therapies

Elsa Abranches, Group Leader, Section Of Stem Cell Biology, NIBSC/MHRA

Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center

Nada Alaaeddine, Head Of The Regenerative And Inflammation Lab In The Faculty Of Medicine, Lebanese University

Nada Alaaeddine | Head Of The Regenerative And Inflammation Lab In The Faculty Of Medicine | Lebanese University » speaking at Advanced Therapies

Marco Alessandrini, Managing Director, Antion Biosciences

Eric Alton, Professor Of Gene Therapy And Respiratory Medicine, Faculty of Medicine National Heart and Lung Institute Imperial College London

Aglaia Athanassiadou, Professor Emeritus, University of Patras

Mimoun Azzouz, Neuroscience Professor, University of Sheffield

Mimoun Azzouz | Neuroscience Professor | University of Sheffield » speaking at Advanced Therapies

Stefano Baila, director of operations, Anemocyte

Anthony Baldor, Business Development And Strategy, 4D Molecular Therapeutics

Anthony Baldor | Business Development And Strategy | 4D Molecular Therapeutics » speaking at Advanced Therapies

Frank Barry, Scientific Director, Regenerative Medicine Institute

Frank Barry | Scientific Director | Regenerative Medicine Institute » speaking at Advanced Therapies

Nina Bauer, Head of Commercial, Milliporesigma Merck Kgaa

Nina Bauer | Head of Commercial | Milliporesigma Merck Kgaa » speaking at Advanced Therapies

Ardeshir Bayat, Senior Associate Professor, The University of Manchester

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Mark Beards, Non Executive Director, Sutura Therapeutics

Francesca Bellintani, Downstream Process Development Manager, MolMed, now part of AGC Biologics

Axel Boehnke, Director Market Access Eu North, PTC Therapeutics

Luc Boileau, Chairman And Chief Executive Officer, INESSS

Luc Boileau | Chairman And Chief Executive Officer | INESSS » speaking at Advanced Therapies

Jeanne Bolger, Vice President of Venture Investments, Johnson & Johnson

Jeanne Bolger | Vice President of Venture Investments | Johnson & Johnson » speaking at Advanced Therapies

Claire Booth, Associate Professor In Gene Therapy, UCL Great Ormond Street Institute of Child Health

Claire Booth | Associate Professor In Gene Therapy | UCL Great Ormond Street Institute of Child Health » speaking at Advanced Therapies

Luis Borges, Chief Scientific Officer, Century Therapeutics

Tara Britt, Associate Chairman, NC Rare Disease Innovations Institute

Tara Britt | Associate Chairman | NC Rare Disease Innovations Institute » speaking at Advanced Therapies

Gabriel Brooks, Vice President, Translational And Clinical Research And Development, 4DMT

Philip J. Brooks, Program Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

Bradley Campbell, Chief Business Officer, Amicus Therapeutics Inc

Iain Campbell, Director Of Nursing And Co-Founder, Wren Healthcare

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Paul S Carter, Director, Head Vector Processing, Quell Therapeutics

Paul S Carter | Director, Head Vector Processing | Quell Therapeutics » speaking at Advanced Therapies

Paul Cashen, Bioprocess Specialist, Pall

Paul Cashen | Bioprocess Specialist | Pall » speaking at Advanced Therapies

Jesus Chaparro Garcia, Quality Control Technician, Cellular Manufacturing Unit,, Regional University Hospital -Biomedical Research Institute (IBIMA) Málaga

Alex Chatel, Product Manager, Univercells Technologies

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Frederic Chereau | Chief Executive Officer | LogicBio Therapeutics » speaking at Advanced Therapies

Pierre-Albert Colcomb, Business Development Manager, Genethon

Pierre-Albert Colcomb | Business Development Manager | Genethon » speaking at Advanced Therapies

Vittorio Colizzi, Professor Of Immunology, University of Rome Tor Vergata

Vittorio Colizzi | Professor Of Immunology | University of Rome Tor Vergata » speaking at Advanced Therapies

Stuart Collinson, Chairman And Chief Executive Officer, Oxstem

Stuart Collinson | Chairman And Chief Executive Officer | Oxstem » speaking at Advanced Therapies

Angela Columbano, Head Of Business Development And Partnership, Genethon

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, VIVET THERAPEUTICS

Elena Costariol, Engd Researcher, UCL

Christina Coughlin, Chief Medical Officer, Rubius Therapeutics

Mr Vicki Coutinho, VP Regulatory Affairs, GammaDelta Therapeutics

Mr Vicki Coutinho | VP Regulatory Affairs | GammaDelta Therapeutics » speaking at Advanced Therapies

Conrad Russell Y Cruz, Assistant Professor, Children's National Medical Center; Co-Founder, Children's National Medical Center

Armando Cuesta Díaz, Partner, Ilana Capital

Vijay Curthan, Investment Director, Catapult Ventures

Vijay Curthan | Investment Director | Catapult Ventures » speaking at Advanced Therapies

Davide Danovi, Director, Hipsci Cell Phenotyping Programme, King's College London

Derek Dashti, Founder And Chief Executive Officer, D and P Bioinnovations

Derek Dashti | Founder And Chief Executive Officer | D and P Bioinnovations » speaking at Advanced Therapies

Eric Michael David, Chief Executive Officer, BridgeBio-Gene Therapy

Gregory Davis, Vice President, Genome Engineering, Sangamo Therapeutics

Michele de Guise, Scientific Vice-President, INESSS

Michele de Guise | Scientific Vice-President | INESSS » speaking at Advanced Therapies

Joery De Kock, Professor, Vrije Universiteit Brussel

Joery De Kock | Professor | Vrije Universiteit Brussel » speaking at Advanced Therapies

Daniel DeVido, Director, Strategic Business Development, Fujifilm Diosynth Biotechnologies

Daniel DeVido | Director, Strategic Business Development | Fujifilm Diosynth Biotechnologies » speaking at Advanced Therapies

Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine

Graciana Diez-Roux | Chief Scientific Officer | Telethon Institute of Genetics and Medicine » speaking at Advanced Therapies

Tanner Dockendorf, Sr. Manager, GMP Nucleic Acids, Aldevron

Tanner Dockendorf | Sr. Manager, GMP Nucleic Acids | Aldevron » speaking at Advanced Therapies

Yizhou Dong, Associate Professor Unit / Department / Division Pharmaceutics and Pharmacology, Ohio State University

Dominik Egger, Research Associate, University Of Natural Resources And Life Sciences Vienna

Magdi Elsallab, Phd Student, Charite

Magdi Elsallab | Phd Student | Charite » speaking at Advanced Therapies

Kris Elverum, Senior Vice President Of Business Development And Strategy, Rubius Therapeutics

Kris Elverum | Senior Vice President Of Business Development And Strategy | Rubius Therapeutics » speaking at Advanced Therapies

Victoria English, Victoria English, Co-Founder And Editor, Evernow Publications

Antoine Espinet, Chief Executive Officer, MicrofluidX

Debora Esposito, Assistant Professor, N.C. State University

Debora Esposito | Assistant Professor | N.C. State University » speaking at Advanced Therapies

Marco Fadda, ATMP Solutions Manager, COMECER GROUP

Marco Fadda | ATMP Solutions Manager | COMECER GROUP » speaking at Advanced Therapies

Dr Suzanne Farid, Professor of Bioprocess Systems Engineering & Co-Director Future Targeted Healthcare Manufacturing Hub, University College London

Dr Suzanne Farid | Professor of Bioprocess Systems Engineering & Co-Director Future Targeted Healthcare Manufacturing Hub | University College London » speaking at Advanced Therapies

Marcie Finney, Associate Director, Cleveland Cord Blood Center

Marcie Finney | Associate Director | Cleveland Cord Blood Center » speaking at Advanced Therapies

Barry Flutter, Gene Therapy Production Manager, Great Ormond Street Institute of Child Health

Barry Flutter | Gene Therapy Production Manager | Great Ormond Street Institute of Child Health » speaking at Advanced Therapies

Miguel Forte, Chief Executive Officer, Bone Therapeutics

Miguel Forte | Chief Executive Officer | Bone Therapeutics » speaking at Advanced Therapies

Mike Fraser, Head of EMEA Region, Novartis Gene Therapies

Thomas Mørch Frøsig, Chief Executive Officer, Immumap

Michela Gabaldo, Head Of Alliance Management, Fondazione Telethon

Chiara Gai, Chair, EvoBiotech

Eli Gajraj, Principal Technical Adviser, National Institute for Health and Care Excellence

Sapan Gandhi, Director, Drishti Discoveries

Daniel Gau, Senior Director External Ventures, Unicyte

André Gerth, Chief Executive Officer, BioPlanta GmbH

Faruque Ghanchi, Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (Born), Specialty Lead- Ophthalmology, Bradford Teaching Hospitals N.H.S. Foundation Trust

Faruque Ghanchi | Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (Born), Specialty Lead- Ophthalmology | Bradford Teaching Hospitals N.H.S. Foundation Trust » speaking at Advanced Therapies

Paul Gissen, LMCB Group Leader, UCL Professorial Research Associate, UCL Great Ormond Street Institute of Child Health

Janet Glassford, senior quality assessor, Medicines & Healthcare Products Regulatory Agency

Janet Glassford | senior quality assessor | Medicines & Healthcare Products Regulatory Agency » speaking at Advanced Therapies

Simon Goldman, Investment Director, Albion Capital

Simon Goldman | Investment Director | Albion Capital » speaking at Advanced Therapies

Matthias Gossmann, Managing Director, InnoVitro

Cecilia Gotherstrom, Research Leader And Associate Professor, Karolinska Institutet

Julian Gough, Chief Scientific Officer, Mogrify

Lise Marie Grav, Postdoc, Technical University of Denmark

Amy Gray, Chief Executive Officer, Charcot-Marie-Tooth Association

David Greenwald, Vice President Of Business Development, Deerfield Management

Uta Griesenbach, Professor, Molecular Medicine, National Heart And Lung Institute; President, British Society For Gene And Cell Therapy;, Imperiai College London

Ravindra Gupta, Professor of Clinical Microbiology, Department of Medicine, University of Cambridge

Ravindra Gupta | Professor of Clinical Microbiology, Department of Medicine | University of Cambridge » speaking at Advanced Therapies

Miriam Haak, Business Development Manager, Miltenyi Biotec GmbH

Miriam Haak | Business Development Manager | Miltenyi Biotec GmbH » speaking at Advanced Therapies

Sam Hall, Partner, Apple Tree Partners

Sam Hall | Partner | Apple Tree Partners » speaking at Advanced Therapies

Brad Hamilton, Co-Founder And Chief Scientific Officer, GoodCell

Peter Hamley, Chief Scientific Officer, Samsara Therapeutics

Peter Hamley | Chief Scientific Officer | Samsara Therapeutics » speaking at Advanced Therapies

Patrick J Hanley, Director, Cellular Therapy Laboratory, Children's National Medical Center

Patrick J Hanley | Director, Cellular Therapy Laboratory | Children's National Medical Center » speaking at Advanced Therapies

Stephen Hart, Professor Of Molecular Genetics, Institute of Child Health - U.C.L.

Hansjorg Hauser, Head Of Department Of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Christopher R Heery, Chief Medical Officer, Precision BioSciences

Nicola Heffron, Senior Vice President, Head of European Operations, Bluebird Bio

Gillian Hendy, Head Of Business Development, Avectas

Gillian Hendy | Head Of Business Development | Avectas » speaking at Advanced Therapies

Dawn Henke, Senior Technical Program Manager, Standards Coordinating Body

Dawn Henke | Senior Technical Program Manager | Standards Coordinating Body » speaking at Advanced Therapies

Asael Herman, CTO, Emendo Biotherapeutics

Christoph Herwig, Professor Of Biochemical Engineering, Vienna University of Technology

Johnny Huard, Director And Chief Scientific Officer, Center For Regenerative Sports Medicine, Steadman Philippon Research Institute

Annie Hubert, Senior Director, European Public Policy, Alliance for Regenerative Medicine

Annie Hubert | Senior Director, European Public Policy | Alliance for Regenerative Medicine » speaking at Advanced Therapies

Nick Hughes, CTO, Arthronica

Michael Hunt, Chief Financial Officer, ReNeuron Group Plc

Dejan Hušman, Chief Executive Officer, denovoMATRIX

John Isaac, Senior Director, External Scientific Innovation And Neuroscience, Johnson & Johnson

John Isaac | Senior Director, External Scientific Innovation And Neuroscience | Johnson & Johnson » speaking at Advanced Therapies

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Agnieszka Janeczek, Founder & Chief Executive Officer, Renovos

Robert Jones, Vice President, Global Bioservices, Cryoport Inc

Troels Jordansen, Chief Executive Officer, Glycostem Therapeutics

Margareth Jorvid, Head Of Regulatory Affairs And Qa, Immunicum

Margareth Jorvid | Head Of Regulatory Affairs And Qa | Immunicum » speaking at Advanced Therapies

Daria Julkowska, Scientific Coordinator, French National Research Agency

Daria Julkowska | Scientific Coordinator | French National Research Agency » speaking at Advanced Therapies

Steve Kanner, Chief Scientific Officer, Caribou Biosciences

Dr Bo Kara, Vice President Process Development, Evox Therapeutics

Cornelia Kasper, Professor, Biopharmaceutical Production And Technology, BOKU

Orion P Keifer, Vice President, Discovery and Translational Research, CODA Biotherapeutics

Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Paul Kemp, Co-Founder & CEO, HairClone

Ralph Kern, Chief Operating Officer & Chief Medical Officer, Brainstorm Cell Therapeutics

Aisha Khan, Executive Director Of Lab Operations At The Interdisciplinary Stem Cell Institute, Miller School of Medicine University of Miami

Sven Kili, Vice President And Head Of Gene Therapy Development, Sven Kili Consulting

Sven Kili | Vice President And Head Of Gene Therapy Development | Sven Kili Consulting » speaking at Advanced Therapies

Soekjoong Kim, R&D Managing Director, ToolGen

Masahiro Kino - Oka, Department of Biotechnology, Graduate School of Engineering,, Osaka University

David H Kirn, Chief Executive Officer, 4D Molecular Therapeutics

David H Kirn | Chief Executive Officer | 4D Molecular Therapeutics » speaking at Advanced Therapies

Jarema (Jarko) Kochan, Head Of Biomarkers, Diagnostics And Assay Development, Turnstone Biologics

Jim Kovach, Director, Innovation

Jim Kovach | Director | Innovation » speaking at Advanced Therapies

Sebastian Kress, Post Doc, BOKU

Maximilian Krippl, Research Assistant, B.O.K.U. University of Natural Resources and Life Sciences Vienna

Jurgen Kuball, Center Of Translational Immunology (Cti), Department Of Hematology, UMC Utrecht

Mohamed Ladha, Head of Commercial, US, Oncopeptides

Mohamed Ladha | Head of Commercial, US | Oncopeptides » speaking at Advanced Therapies

Lawrence Lamb, Executive Vice President And Chief Scientific Officer, Incysus Therapeutics

Michael Lanero Fidalgo, COO, TreeFrog Therapeutics

Christine Le Bec, Head of CMC Gene Therapy, working on AAV vectors, Sensorion Sas

Christine Le Bec | Head of CMC Gene Therapy, working on AAV vectors | Sensorion Sas » speaking at Advanced Therapies

Steven Lee, Senior Research Fellow, Institute Of Immunology And Immunotherapy, University of Birmingham

Bruce Levine, Professor, Perelman School of Medicine University of Pennsylvania

Nanxin (Nick) Li, Senior Director and Head, Health Economics and Outcomes Research (HEOR), uniQure

Tongri Liu, Chief Representative, Allife Medicine

Diana Lober, Product Manager, Schott AG

Anthony Lodge, CMC – Regulatory Lead, Kite Pharma, a Gilead Company

Friedemann Loos, Innovation Manager, BioRN Cluster Management Gmbh

Douglas Losordo, Chief Medical Officer, Caladrius Biosciences

Douglas Losordo | Chief Medical Officer | Caladrius Biosciences » speaking at Advanced Therapies

Tim Luker, Global Director, External Innovation, External Research And Development, Eli Lilly And Company

Tim Luker | Global Director, External Innovation, External Research And Development | Eli Lilly And Company » speaking at Advanced Therapies

Frank Luyten, Director, Katholeieke Universiteit Leuven

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Ross Macdonald | Chief Executive Officer | Cynata Therapeutics Ltd » speaking at Advanced Therapies

John Maher, CSO, Leucid Bio

Michel Manach, Business Development Manager, Cell-Easy

Rachel Manley, Head Of Global Outreach, Save the Cord Foundation

Sakis Mantalaris, Professor, Biomedical Systems Engineering Laboratory, Georgia Institute of Technology

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

Peter Marks | Director, Center For Biologics Evaluation And Research (CBER) | U.S. Food and Drug Administration » speaking at Advanced Therapies

Thomas Marx, Head of Business Development, Rheincell Therapeutics GmbH

Fernanda Masri, Segment Marketing Manager, Advanced Therapies, Sartorius Stedim BioOutsource Ltd

Giuseppe Mazza, Chief Executive And Scientific Officer, Engitix

Giuseppe Mazza | Chief Executive And Scientific Officer | Engitix » speaking at Advanced Therapies

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Todd C Mcdevitt, Senior Investigator, Gladstone Institute

Todd C Mcdevitt | Senior Investigator | Gladstone Institute » speaking at Advanced Therapies

Neil Mcgowan, Head of Manufacturing, SNBTS Cellular Therapy Development Centre

Thomas Meany, Director, OpenCell.bio

Sarah Meeks, Vice President Of Business Development, MaxCyte

Rob Meijer, Chief Executive Officer, Amphera

Leslie Meltzer, Vice President And Head Of Global Medical Affairs, Orchard Therapeutics

Janneke Meulenberg, Chief Operating Officer, Arthrogen Bv

Janneke Meulenberg | Chief Operating Officer | Arthrogen Bv » speaking at Advanced Therapies

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller | Chief Scientific Officer | Cell Therapy Sciences » speaking at Advanced Therapies

Aline Miller, Chief Executive Officer, Manchester BIOGEL

Federico Mingozzi, Chief Scientific Officer, Spark Therapeutics

Federico Mingozzi | Chief Scientific Officer | Spark Therapeutics » speaking at Advanced Therapies

Neill Moray Mackenzie, Chairman And Board Mamber, Immetacyte

Neill Moray Mackenzie | Chairman And Board Mamber | Immetacyte » speaking at Advanced Therapies

Paolo Morgese, Director, Market Access And Member Relations, Alliance for Regenerative Medicine

Dave C Morris, Vice President Of Therapeutic Discovery, Precision BioSciences

David Morrow, Project Manager, EATRIS

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy | Principle Investigator | Remedi National University of Ireland Galway » speaking at Advanced Therapies

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Susan Nichols, President And Chief Executive Officer, Falcon Therapeutics

Susan Nichols | President And Chief Executive Officer | Falcon Therapeutics » speaking at Advanced Therapies

Charis Ober, Founder And Executive Director, Save the Cord Foundation

Charis Ober | Founder And Executive Director | Save the Cord Foundation » speaking at Advanced Therapies

Jelena Ochs, Research Associate, Fraunhofer Institute for Production Technology

Shirley O'Dea, Chief Scientific Officer, Avectas

Steve Oh, Stem Cell Bioprocessing Director And Institute Professor, A-star

Daniel O'Mahony, Partner, Seroba Life Sciences

Christina O'Neill, CEO, VascVersa

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC

Nneka Onwudiwe | Founder And Chief Executive Officer | Pharmaceutical Economics Consultants of America (PECA) LLC » speaking at Advanced Therapies

Dominic O'Regan, Business Development Consultant & Investor, New Mosaic

Emanuele Ostuni, Head Of Europe, Cell And Gene Therapy, Novartis

Emanuele Ostuni | Head Of Europe, Cell And Gene Therapy | Novartis » speaking at Advanced Therapies

Myriam Ouberai, Founder & CEO, Spirea

Sean Palecek, Director for Research, University of Wisconsin, Stem Cell and Regenerative Medicine Center

Ioannis Papantoniou, Adjunct Professor, KU Leuven

Maria Papathanasiou, Lecturer, Imperiai College London

Maria Papathanasiou | Lecturer | Imperiai College London » speaking at Advanced Therapies

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Vivienne Parry, Head Of Engagement, Genomics England

Vivienne Parry | Head Of Engagement | Genomics England » speaking at Advanced Therapies

Rikesh Patel, Strategic Partnerships Lead, MedCity

Rikesh Patel | Strategic Partnerships Lead | MedCity » speaking at Advanced Therapies

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

David Pearce, President Of Innovation And Research, Sanford Research

Adam Perriman, Professor of Bioengineering, University of Bristol

Edmund Pezalla, CEO, Enlightenment Bioconsult

Edmund Pezalla | CEO | Enlightenment Bioconsult » speaking at Advanced Therapies

Marjolaine Phan, Early Development Regulatory Director, Novartis

Marjolaine Phan | Early Development Regulatory Director | Novartis » speaking at Advanced Therapies

Elzbieta Maria Piatkowska, Chief Executive Officer, Remissio UG

Elzbieta Maria Piatkowska | Chief Executive Officer | Remissio UG » speaking at Advanced Therapies

Steven Pincus, Head Of Science And Innovation, Fujifilm Diosynth Biotechnology

Stefano Pirro, Co-founder and Bioinformatics Director, MirNat

Avery Posey, Assistant Professor, University of Pennsylvania

Martin Pule, Senior Vice President, Founder, Chief Scientific Officer, Autolus and Clinical Senior Lecturer, University College London

Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London

Abdulkader Rahmo, CEO / CSO, SMSbiotech

Lior Raviv, Vice President Of Development, Pluristem Therapeutics

Antonio Regalado, Senior Editor, M.I.T. Technology Review

Antonio Regalado | Senior Editor | M.I.T. Technology Review » speaking at Advanced Therapies

Ajan Reginald, Chief Executive Officer, Celixir

Petra Reinke, Founding Director, Becat, Steering Committee Bcrt, Charite

Albert Ribickas, Bmt/Qc Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Jim Richardson, Senior Science And Standards Liaison, U.S. Pharmacopeia

Jim Richardson | Senior Science And Standards Liaison | U.S. Pharmacopeia » speaking at Advanced Therapies

Erik Richardson, Senior Manager, Gene Therapy R&D, Apellis Pharmaceuticals

Erik Richardson | Senior Manager, Gene Therapy R&D | Apellis Pharmaceuticals » speaking at Advanced Therapies

Dr Barry Rosen, Senior Principal Scientist And Director, AstraZeneca

Vince Rotello, Charles A. Goessmann Professor of Chemistry and a University Distinguished Professor, University of Massachusetts Amherst

Nicolas Rousseau, Chief Operating Officer, EVerZom

Christoph Ruedig, Partner, AlbionVC

Carlo Russo, CMO/Head Dev, Genenta Science

Carlo Russo | CMO/Head Dev | Genenta Science » speaking at Advanced Therapies

Pervinder Sagoo, Director, Gene And Cell Therapy, Orchard Therapeutics

Mark Sawicki, cco, Cryoport Inc

David Schaffer, Professor, Chemical And Biomolecular Engineering, University Of California, Berkeley And Co-Founder, 4D Molecular Therapeutics

Dominic Schmidt, Partner, Syncona Investment Management Ltd

Stephanie Schorge, Professor Of Translational Neuroscience And The Wellcome Chair Of Pharmacology, University College London

Jan Schrooten, Board Member, Flanders.Bio And Chief Executive Officer, Antleron

Raghuram Selvaraju, Managing Director, h.c. wainwright

Raghuram Selvaraju | Managing Director | h.c. wainwright » speaking at Advanced Therapies

Raghuram Selvaraju, Managing Director, Senior Analyst, Healthcare, h.c. wainwright

Raghuram Selvaraju | Managing Director, Senior Analyst, Healthcare | h.c. wainwright » speaking at Advanced Therapies

Margarida Serra, Head Of Stem Cell Bioengineering Laboratory, iBET: Instituto de Biologia Experimental e Tecnológica

Ra Session II, Chief Business Officer, BridgeBio-Gene Therapy

Ra Session II | Chief Business Officer | BridgeBio-Gene Therapy » speaking at Advanced Therapies

Jaime Shamonki, Chief Medical Officer, CBR by Generate Life Sciences

Jaime Shamonki | Chief Medical Officer | CBR by Generate Life Sciences » speaking at Advanced Therapies

Maryam Shariatzadeh, Post-Doctoral Researcher, Centre For Biological Engineering, Loughborough University

Gerard Short, svp medical science, Freeline Therapeutics

Gerard Short | svp medical science | Freeline Therapeutics » speaking at Advanced Therapies

Ricardo Silva, Senior Scientist, Instituto de Biologia Experimental e Tecnologica

Alex Sim, President, Amsbio

Alex Sim | President | Amsbio » speaking at Advanced Therapies

John Sinden, Chief Executive Officer, Glialign Limited

Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England

Yochi Slonim, Co-Founder And Chief Executive Officer, Anima Biotech

Owen Smith, Investment Director, 4Bio Capital

Owen Smith | Investment Director | 4Bio Capital » speaking at Advanced Therapies

Devyn Smith, Chief Operating Officer And Head Of Strategy, Sigilon

Luce Sohier, Business Development Sterile Solutions, Schott AG

Mangala Srinivas, Head Of Multiscale Imaging Lab, Radboud University

Mangala Srinivas | Head Of Multiscale Imaging Lab | Radboud University » speaking at Advanced Therapies

Dr Glyn Stacey, Executive Director, International Stem Cell Banking Initiative

Dr Glyn Stacey | Executive Director | International Stem Cell Banking Initiative » speaking at Advanced Therapies

Joseph Stavas, Senior Vice President of Clinical Development, inRegen

Joseph Stavas | Senior Vice President of Clinical Development | inRegen » speaking at Advanced Therapies

Junwei Sun, Administrator Center for Advanced Ocular and Ophthalmic Therapeutics, University of Pennsylvania

Mathias Svahn, Chief Executive Officer, Nextcell Pharma

Mathias Svahn | Chief Executive Officer | Nextcell Pharma » speaking at Advanced Therapies

Magali Taiel, CMO, GenSight Biologics

Marina Tarunina, Research Director, Plasticell

Bill Tente, Chief Regulatory Officer, Humacyte

Bill Tente | Chief Regulatory Officer | Humacyte » speaking at Advanced Therapies

Stefanos Theoharis, Previously Senior Vice President Of Corporate Development And Partnering, Cell Medica, Independent Consultant

Stefanos Theoharis | Previously Senior Vice President Of Corporate Development And Partnering, Cell Medica | Independent Consultant » speaking at Advanced Therapies

Hartmut Tintrup, Global Head of Business Development, Lonza

Pascal Touchon, President, Chief Executive Officer And Board Member, Atara Biotherapeutics

Pamela Tranter, Translational Reserach Manager, University College London

Ted Tuddenham, Emeritus Professor Of Haemophilia, University College London

Ted Tuddenham | Emeritus Professor Of Haemophilia | University College London » speaking at Advanced Therapies

Sheela Upadhyaya, Rare Disease Expert, National Institute for Health and Care Excellence

Sheela Upadhyaya | Rare Disease Expert | National Institute for Health and Care Excellence » speaking at Advanced Therapies

Evelina Vågesjo, Chief Executive Officer, Ilya Pharma

Edward Van Wezel, partner, Bgv Biogeneration Ventures

Tarun Vemulkar, Co-Founder & CTO, Semarion

David Venables, President, AskBio Europe, askbio

Jeroen Verheyen, Co-Founder And CEO, Semarion

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Simon Waddington, Professor of Gene Therapy, UCL

John Wagner, Executive Medical Director Of B.M.T. Program, University of Minnesota

John Wagner | Executive Medical Director Of B.M.T. Program | University of Minnesota » speaking at Advanced Therapies

Darren Walsh, Senior Director - Market Access And Government Affairs - Eu, Orchard Therapeutics

Lilian Walther Jallow, Senior researcher, Karolinska Institutet

Dr Michael West, Founder And Chief Executive Officer, AgeX Therapeutics

Sam Whitehouse, Chief Executive Officer, LightOx

Sam Whitehouse | Chief Executive Officer | LightOx » speaking at Advanced Therapies

David Wilson, Vice President EMEA, Cryoport Inc

David Wilson | Vice President EMEA | Cryoport Inc » speaking at Advanced Therapies

Phil Wilson, Senior Vice President Of Global Operations And Supply Chain, Cryoport

Tom Wilton, Chief Business Officer, Carisma Therapeutics

Stefano Zancan, Head Clinical Development And Operations, Fondazione Telethon

Annalisa Zucotti, Comm And Events Lead, BioRN

Annalisa Zucotti | Comm And Events Lead | BioRN » speaking at Advanced Therapies

 

 

 

“Let me congratulate you on a job well done in helping organise the speakers and presentations for last week's Advanced Therapies Congress. I thought the entire meeting had a lot of substance, which made it stand out from many other meetings.”

 

Editor, Evernow Publishing Ltd